Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Japanese NHI price listing for Nicotinell TTS

June 2, 2006

Proof-of-concept study for NicVAX in smoking cessation

May 29, 2006

Recent Merz patent discloses novel agents for drug addiction

May 24, 2006

SRI awarded NIAID contract to produce oral formulations for antiradiation drugs

May 23, 2006

FDA approval for smoking cessation therapy Chantix

May 12, 2006

Celtic cleared in U.K. to begin phase II study of TA-NIC

May 9, 2006

BioTie grants Britannia nalmefene marketing rights for U.K. and Ireland

May 4, 2006

Vivitrol approved for treatment of alcohol dependence

April 18, 2006

Galantamine and smoking cessation / News in Context

April 3, 2006

NicVAX awarded fast track designation

March 13, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...